• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.

作者信息

Balakrishnan S, Ramu G

出版信息

Lepr India. 1977 Jan;49(1):59-64.

PMID:330945
Abstract

The plasma DDS clearance rates and the acetylation rates of Sulphadimidine were studied in a group of 30 leprosy patients comprising of 17 non-responders and 13 responders to DDS treatment. No differences in the acetylator type or in the plasma DDS clearance were seen between the responders and non-responders. Acetylation rate did not bear any relation to the plasma clearance of DDS in the non-responders. The findings indicate that the resistance to DDS therapy in these patients is not related to any abnormal metabolic disposition of DDS.

摘要

相似文献

1
Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
Lepr India. 1977 Jan;49(1):59-64.
2
Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.麻风病患者乙酰化酶表型对氨苯砜耐药麻风病出现的影响。
Indian J Lepr. 1988 Jul;60(3):400-6.
3
The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS.哥斯达黎加瘤型麻风患者中氨苯砜耐药的发生率:他们对氨苯砜的代谢情况。
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):143-51.
4
The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.有过治疗史和无治疗史的麻风分枝杆菌对氨苯砜(DDS)的敏感性。
Am J Trop Med Hyg. 1969 Mar;18(2):258-63.
5
Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.从长期接受氨苯砜治疗的麻风病人中分离出的麻风杆菌的药物敏感性。
Acta Leprol. 1978 Oct-Dec(73):13-28.
6
[Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].[麻风分枝杆菌对氨苯砜和利福平的耐药性:关于在佛得角地区(塞内加尔)开展的一项调查]
Med Trop (Mars). 1987 Apr-Jun;47(2):171-5.
7
Acedapsone treatment of leprosy patients: response versus drug disposition.氨苯砜治疗麻风病患者:疗效与药物处置
Am J Trop Med Hyg. 1977 Jan;26(1):127-36. doi: 10.4269/ajtmh.1977.26.127.
8
Dapsone resistance in Mycobacterium leprae.麻风分枝杆菌中的氨苯砜耐药性。
Lepr Rev. 2000 Dec;71 Suppl:S91-5.
9
[2 cases of paucibacillary leprosy resistant to dapsone].2例对氨苯砜耐药的少菌型麻风病
Acta Leprol. 1982 Jan-Jun(86-87):181-3.
10
DDS resistance in Ethiopia - a progress report.埃塞俄比亚的耐二性双胍类药物——一份进展报告。
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):140-2.

引用本文的文献

1
Clinical pharmacokinetics of dapsone.氨苯砜的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):299-315. doi: 10.2165/00003088-198611040-00003.
2
Clinical pharmacokinetic considerations in the treatment of patients with leprosy.麻风病患者治疗中的临床药代动力学考量
Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.